Search of: Open Studies | "Neoplasms" - List Results

Home


	List Results


	Refine Search


	Results by Topic


	Results on Map


	Search Details

Found 8184 studies with search of:

Open Studies | "Neoplasms"

Display Options

1	Recruiting	Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer
		Conditions:	Adrenocortical Carcinoma; Breast Cancer; Colorectal Cancer; Gastrointestinal Cancer; Kidney Cancer; Liver Cancer; Melanoma (Skin); Ovarian Cancer; Pancreatic Cancer; Sarcoma
		Interventions:	Drug: colloidal gold-bound tumor necrosis factor; Procedure: conventional surgery; Procedure: electron microscopy; Procedure: pharmacological study

2	Recruiting	Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer or Other Solid Tumors
		Conditions:	Breast Cancer; Extragonadal Germ Cell Tumor; Gestational Trophoblastic Tumor; Kidney Cancer; Lung Cancer; Neuroblastoma; Ovarian Cancer; Sarcoma; Testicular Germ Cell Tumor; Unspecified Adult Solid Tumor, Protocol Specific
		Interventions:	Drug: aldesleukin; Drug: busulfan; Drug: carboplatin; Drug: cyclophosphamide; Drug: etoposide; Drug: filgrastim; Drug: ifosfamide; Drug: paclitaxel; Drug: sargramostim; Drug: therapeutic autologous lymphocytes; Procedure: bone marrow ablation with stem cell support; Procedure: peripheral blood stem cell transplantation

3	Recruiting	Cognitive and Behavioral Therapy or Standard Care in Patients With Advanced Gastrointestinal Cancer or Lung Cancer
		Conditions:	Anxiety Disorder; Colorectal Cancer; Depression; Esophageal Cancer; Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Gastric Cancer; Liver Cancer; Lung Cancer; Pancreatic Cancer; Psychosocial Effects/Treatment
		Interventions:	Procedure: counseling; Procedure: educational intervention; Procedure: meditation therapy; Procedure: psychosocial assessment and care; Procedure: quality-of-life assessment; Procedure: questionnaire administration; Procedure: standard follow-up care

4	Recruiting	ChemoFx® Observational Study in Gynecological Solid Tumors
		Conditions:	Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Neoplasms; Uterine Cancer; Endometrial Cancer; Vaginal Cancer; Vulvar Cancer; Cervical Cancer
		Intervention:

5	Recruiting	Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors
		Conditions:	Breast Cancer; Colorectal Cancer; Head and Neck Cancer; Lung Cancer; Melanoma (Skin); Ovarian Cancer; Pancreatic Cancer; Prostate Cancer; Unspecified Adult Solid Tumor, Protocol Specific
		Interventions:	Drug: bortezomib; Drug: paclitaxel; Procedure: high performance liquid chromatography; Procedure: immunohistochemistry staining method; Procedure: laboratory biomarker analysis; Procedure: pharmacological study; Procedure: protein expression analysis; Procedure: western blotting

6	Recruiting	High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors
		Conditions:	Childhood Germ Cell Tumor; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Neuroblastoma; Testicular Germ Cell Tumor; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
		Interventions:	Drug: busulfan; Drug: carboplatin; Drug: carmustine; Drug: cyclophosphamide; Drug: etoposide; Drug: melphalan; Drug: thiotepa; Procedure: total-body irradiation

7	Recruiting	Biomarkers and Radiation Side Effects in Patients Undergoing Radiation Therapy for Gastrointestinal Cancer
		Conditions:	Colorectal Cancer; Esophageal Cancer; Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Gastric Cancer; Gastrointestinal Complications; Liver Cancer; Pancreatic Cancer; Radiation Toxicity
		Interventions:	Procedure: DNA methylation analysis; Procedure: laboratory biomarker analysis; Procedure: management of therapy complications; Procedure: mutation analysis; Procedure: observation; Procedure: polymerase chain reaction

8	Recruiting	Tariquidar and Docetaxel in Treating Patients With Recurrent or Metastatic Lung, Ovarian, Cervical Cancer, or Kidney Cancer
		Conditions:	Cervical Cancer; Fallopian Tube Cancer; Kidney Cancer; Lung Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
		Interventions:	Drug: docetaxel; Drug: tariquidar

9	Recruiting	Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
		Conditions:	Brain and Central Nervous System Tumors; Intraocular Melanoma; Lung Cancer; Melanoma (Skin); Metastatic Cancer; Neuroblastoma; Ovarian Cancer; Retinoblastoma; Sarcoma; Small Intestine Cancer
		Interventions:	Drug: iodine I 131 monoclonal antibody 3F8; Procedure: immunologic technique; Procedure: pharmacological study

10	Recruiting	Peripheral Stem Cell Transplant and White Blood Cell Transfusions in Treating Patients With Refractory Metastatic Solid Tumors
		Conditions:	Breast Cancer; Carcinoma of Unknown Primary; Colorectal Cancer; Esophageal Cancer; Gallbladder Cancer; Gastric Cancer; Liver Cancer; Lung Cancer; Pancreatic Cancer; Prostate Cancer; Sarcoma
		Interventions:	Drug: anti-thymocyte globulin; Drug: cyclophosphamide; Drug: cyclosporine; Drug: fludarabine phosphate; Drug: therapeutic allogeneic lymphocytes; Procedure: peripheral blood stem cell transplantation

11	Recruiting	Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer
		Conditions:	Anal Cancer; Carcinoma of the Appendix; Colorectal Cancer; Esophageal Cancer; Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Gastric Cancer; Gastrointestinal Carcinoid Tumor; Gastrointestinal Stromal Tumor; Liver Cancer; Pancreatic Cancer; Small Intestine Cancer
		Interventions:	Drug: fluorouracil; Drug: irinotecan hydrochloride; Drug: leucovorin calcium; Procedure: pharmacogenomic studies; Procedure: pharmacological study

12	Recruiting	Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer
		Conditions:	Breast Cancer; Cervical Cancer; Endometrial Cancer; Fallopian Tube Cancer; Ovarian Cancer; Prostate Cancer; Sarcoma; Vaginal Cancer; Vulvar Cancer
		Interventions:	Procedure: gene expression analysis; Procedure: gene rearrangement analysis; Procedure: laboratory biomarker analysis; Procedure: polymorphism analysis; Procedure: radiation therapy

13	Recruiting	Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors
		Conditions:	Breast Cancer; Colorectal Cancer; Head and Neck Cancer; Kidney Cancer; Lung Cancer; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer; Sarcoma; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific
		Interventions:	Drug: bortezomib; Drug: gemcitabine hydrochloride; Procedure: pharmacological study

14	Recruiting	Nelfinavir in Treating Patients With Metastatic, Refractory, or Recurrent Solid Tumors
		Conditions:	Colorectal Cancer; Gastrointestinal Carcinoid Tumor; Head and Neck Cancer; Islet Cell Tumor; Lung Cancer; Metastatic Cancer; Neuroendocrine Carcinoma of the Skin; Ovarian Cancer; Pheochromocytoma; Sarcoma; Unspecified Adult Solid Tumor, Protocol Specific
		Interventions:	Drug: midazolam hydrochloride; Drug: nelfinavir mesylate; Procedure: gene expression analysis; Procedure: immunoenzyme technique; Procedure: immunologic technique; Procedure: laboratory biomarker analysis; Procedure: mass spectrometry; Procedure: pharmacological study; Procedure: polymerase chain reaction; Procedure: protein expression analysis

15	Recruiting	A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors
		Conditions:	Bladder Cancer; Breast Cancer; Colorectal Cancer; Gastrointestinal Neoplasm; Head and Neck Cancer; Lung Cancer; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer
		Intervention:	Drug: Picoplatin

16	Recruiting	Questionnaire Study for Gynecological Cancer Survivors
		Conditions:	Endometrial Neoplasms; Ovarian Neoplasms; Uterine Cervical Neoplasms; Vulvar Neoplasms; Vaginal Neoplasms; Genital Neoplasms, Female
		Intervention:	Behavioral: Psychosocial

17	Recruiting	Busulfan, Melphalan, Topotecan, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor
		Conditions:	Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Kidney Cancer; Neuroblastoma; Ovarian Cancer; Sarcoma; Testicular Germ Cell Tumor; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific
		Interventions:	Drug: busulfan; Drug: filgrastim; Drug: melphalan; Drug: topotecan hydrochloride; Procedure: autologous bone marrow transplantation; Procedure: autologous hematopoietic stem cell transplantation; Procedure: pharmacological study

18	Recruiting	Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer
		Conditions:	Brain Neoplasms; Lung Neoplasms; Thyroid Neoplasms; Colorectal Neoplasms; Lymphoma
		Intervention:	Procedure: Positron Emission Tomography (PET) scan

19	Recruiting	Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma
		Conditions:	Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Head and Neck Cancer; Lymphoma; Nausea and Vomiting; Neuroblastoma; Ovarian Cancer; Sarcoma
		Interventions:	Procedure: electroacupuncture therapy; Procedure: management of therapy complications; Procedure: nausea and vomiting therapy

20	Recruiting	Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer
		Conditions:	Cervical Cancer; Endometrial Cancer; Fallopian Tube Cancer; Gestational Trophoblastic Tumor; Ovarian Cancer; Perioperative/Postoperative Complications; Sarcoma; Thromboembolism; Vaginal Cancer; Vulvar Cancer
		Intervention:	Drug: fondaparinux sodium

21	Recruiting	Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors
		Conditions:	Bladder Cancer; Breast Cancer; Colorectal Cancer; Esophageal Cancer; Fatigue; Lung Cancer; Lymphoma; Ovarian Cancer; Prostate Cancer
		Interventions:	Procedure: complementary or alternative medicine procedure; Procedure: exercise intervention; Procedure: fatigue assessment and management; Procedure: physical therapy

22	Recruiting	Trabectedin in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
		Conditions:	Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Kidney Cancer; Liver Cancer; Neuroblastoma; Ovarian Cancer; Sarcoma; Unspecified Childhood Solid Tumor, Protocol Specific
		Interventions:	Drug: filgrastim; Drug: pegfilgrastim; Drug: trabectedin

23	Recruiting	Natural Killer Cells and Bortezomib to Treat Cancer
		Conditions:	Lung or Prostatic Neoplasms; Colorectal or Kidney Neoplasms; Pancreatic Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanoma
		Intervention:	Drug: NK cells +CliniMACs CD3 and CD56 systems

24	Not yet recruiting	Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers
		Conditions:	Colorectal Cancer; Lung Cancer; Ovarian Cancer; Pancreatic Cancer
		Interventions:	Procedure: quality-of-life assessment; Procedure: questionnaire administration

25	Recruiting	Cyclophosphamide and Fludarabine Followed By White Blood Cell Infusion and High-Dose Aldesleukin in Treating Patients With Metastatic Cancer That Overexpresses p53
		Conditions:	Breast Cancer; Colorectal Cancer; Kidney Cancer; Lung Cancer; Melanoma (Skin); Ovarian Cancer; Pancreatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific
		Interventions:	Drug: aldesleukin; Drug: anti-p53 T-cell receptor-transduced peripheral blood lymphocytes; Drug: cyclophosphamide; Drug: filgrastim; Drug: fludarabine phosphate; Drug: therapeutic autologous lymphocytes

26	Recruiting	Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy
		Conditions:	Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Kidney Cancer; Leukemia; Liver Cancer; Neuroblastoma; Ovarian Cancer; Sarcoma; Unspecified Childhood Solid Tumor, Protocol Specific
		Intervention:	Drug: ixabepilone

27	Recruiting	Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer
		Conditions:	Breast Cancer; Colorectal Cancer; Lung Cancer; Malignant Mesothelioma; Prostate Cancer; Psychosocial Effects/Treatment; Quality of Life; Thymoma and Thymic Carcinoma
		Intervention:	Procedure: educational intervention

28	Recruiting	Ixabepilone and Liposomal Doxorubicin in Treating Women With Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer or Metastatic Breast Cancer
		Conditions:	Breast Cancer; Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
		Interventions:	Drug: ixabepilone; Drug: pegylated liposomal doxorubicin hydrochloride

29	Recruiting	Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors
		Conditions:	Breast Cancer; Colorectal Cancer; Head and Neck Cancer; Lung Cancer; Malignant Mesothelioma; Pancreatic Cancer; Prostate Cancer; Sarcoma
		Interventions:	Drug: cisplatin; Drug: pemetrexed disodium; Drug: sorafenib tosylate

30	Recruiting	Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
		Conditions:	Gastrointestinal Carcinoid Tumor; Head and Neck Cancer; Islet Cell Tumor; Kidney Cancer; Lung Cancer; Melanoma (Skin); Neuroendocrine Carcinoma of the Skin; Pheochromocytoma; Unspecified Adult Solid Tumor, Protocol Specific
		Interventions:	Drug: everolimus; Drug: vatalanib; Procedure: dynamic contrast-enhanced magnetic resonance imaging; Procedure: high performance liquid chromatography; Procedure: immunohistochemistry staining method; Procedure: laboratory biomarker analysis; Procedure: mass spectrometry; Procedure: pharmacological study; Procedure: protein expression analysis; Procedure: ultrasound imaging

31	Recruiting	Chemotherapy With Whole Body Hyperthermia to Treat Resistant Breast, Endometrial, Cervical and Ovarian Cancers
		Conditions:	Breast Neoplasms; Endometrial Neoplasms; Cervix Neoplasms; Ovarian Neoplasms
		Intervention:	Other: thermochemotherapy (with 5-fluorouracil/interferon-a/liposomal doxorubicin)

32	Recruiting	Family Quality of Life Among Families With a Member Who is a Cancer Patient
		Conditions:	Breast Cancer; Colorectal Cancer; Head and Neck Cancer; Lung Cancer; Prostate Cancer; Unspecified Adult Solid Tumor, Protocol Specific
		Interventions:	Procedure: quality-of-life assessment; Procedure: questionnaire administration; Procedure: survey administration

33	Recruiting	Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands, United Kingdom
		Conditions:	Bladder Cancer; Brain and Central Nervous System Tumors; Esophageal Cancer; Intraocular Melanoma; Kidney Cancer; Lymphoma; Melanoma (Skin); Pancreatic Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter
		Interventions:	Procedure: DNA analysis; Procedure: laboratory biomarker analysis; Procedure: polymorphism analysis; Procedure: questionnaire administration

34	Recruiting	Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer
		Conditions:	Pancreatic Cancer; Pancreas Neoplasms; Cancer of Pancreas; Neoplasms, Pancreatic; Pancreas Cancer
		Intervention:	Biological: VEGFR1-A24-1084 (SYGVLLWEI)

35	Recruiting	Human Leukocyte Antigen-A*0201-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer
		Conditions:	Pancreatic Cancer; Pancreas Neoplasms; Cancer of Pancreas; Neoplasms, Pancreas; Pancreas Cancer
		Intervention:	Biological: VEGFR1-A02-770 (TLFWLLLTL)

36	Recruiting	Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
		Conditions:	Breast Cancer; Cognitive/Functional Effects; Colorectal Cancer; Lung Cancer; Pain; Prostate Cancer; Psychosocial Effects/Treatment
		Interventions:	Procedure: assessment of therapy complications; Procedure: cognitive assessment; Procedure: psychosocial assessment and care

37	Recruiting	Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer
		Conditions:	Breast Cancer; Lung Cancer; Metastatic Cancer; Pain; Prostate Cancer
		Interventions:	Drug: calcium carbonate; Drug: calcium citrate; Drug: calcium glucarate; Drug: calcium gluconate; Drug: samarium Sm 153 lexidronam pentasodium; Drug: strontium chloride Sr 89; Drug: vitamin D; Drug: zoledronic acid

38	Recruiting	Cediranib in Treating Young Patients With Refractory or Recurrent Solid Tumors or Acute Myeloid Leukemia
		Conditions:	Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Kidney Cancer; Leukemia; Liver Cancer; Neuroblastoma; Ovarian Cancer; Sarcoma; Unspecified Childhood Solid Tumor, Protocol Specific
		Interventions:	Drug: cediranib; Procedure: laboratory biomarker analysis; Procedure: pharmacological study

39	Recruiting	Fluorouracil, Hydroxyurea, Cetuximab and Twice-Daily Intensity Radiation Therapy for Advanced Head and Neck Cancer
		Conditions:	Head and Neck Cancer; Cancer of the Pharynx; Cancer of the Larynx; Nose Neoplasms; Paranasal Sinus Neoplasms; Cancer of the Oral Cavity
		Interventions:	Drug: cetuximab; Drug: hydroxyurea; Drug: fluorouracil; Procedure: chemotherapy; Procedure: radiotherapy

40	Recruiting	Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant
		Conditions:	Breast Cancer; Chronic Myeloproliferative Disorders; Colorectal Cancer; Infection; Leukemia; Lung Cancer; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Precancerous/Nonmalignant Condition; Unspecified Adult Solid Tumor, Protocol Specific
		Interventions:	Procedure: management of therapy complications; Procedure: observation

41	Recruiting	Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities
		Conditions:	Breast Cancer; Cervical Cancer; Prostate Cancer; Colorectal Cancer; Lung Cancer
		Intervention:	Behavioral: Questionnaire

42	Recruiting	Pain in Cancer Survivors
		Conditions:	Breast Cancer; Colorectal Cancer; Prostate Cancer; Head and Neck Cancer; Lung Cancer
		Intervention:	Behavioral: Telephone interview or self report survey.

43	Recruiting	Conditioning Regimens and One or Two Autologous Peripheral Stem Cell Transplants in Treating Patients With Germ Cell Tumors
		Conditions:	Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Ovarian Cancer; Teratoma; Testicular Germ Cell Tumor
		Interventions:	Drug: carboplatin; Drug: cyclophosphamide; Drug: etoposide; Drug: filgrastim; Drug: ifosfamide; Drug: paclitaxel; Drug: thiotepa; Procedure: autologous hematopoietic stem cell transplantation; Procedure: peripheral blood stem cell transplantation

44	Recruiting	The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer
		Conditions:	Cancer; Breast Cancer; Colon Cancer; Cervical Cancer; Uterine Cancer; Ovarian Cancer
		Interventions:	Other: Very low carbohydrate diet (Approximately 20 grams per day); Other: Very low carbohydrate diet

45	Recruiting	Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer
		Conditions:	Breast Cancer; Colorectal Cancer; Pancreatic Cancer; Bladder Cancer; Ovarian Cancer
		Intervention:	Biological: CDX-1307

46	Recruiting	Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma
		Conditions:	Breast Cancer; Endometrial Cancer; Kidney Cancer; Lung Cancer; Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific
		Interventions:	Drug: metformin hydrochloride; Drug: temsirolimus

47	Recruiting	A Study of CDX-1307, in Patients With Incurable Breast, Colorectal, Pancreatic, Ovarian or Bladder Cancer
		Conditions:	Breast Cancer; Colorectal Cancer; Pancreatic Cancer; Bladder Cancer; Ovarian Cancer
		Intervention:	Biological: CDX1307

48	Recruiting	A Phase II Study of AZD4877 (a Novel Anti-Mitotic Agent) in Advanced Bladder Cancer
		Conditions:	Bladder Cancer; Transitional Cell Bladder Cancer; Urethra Cancer; Ureter Cancer; Renal Pelvis Cancer
		Intervention:	Drug: AZD4877

49	Recruiting	Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer
		Conditions:	Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Gastric Cancer; Liver Cancer; Unspecified Adult Solid Tumor, Protocol Specific
		Interventions:	Drug: capecitabine; Drug: carboplatin; Drug: epirubicin hydrochloride; Procedure: gene expression profiling; Procedure: pharmacological study; Procedure: polymorphism analysis

50	Recruiting	Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer Patients
		Conditions:	Anal Cancer; Colorectal Cancer; Esophageal Cancer; Gastric Cancer; Lung Cancer
		Intervention:	Behavioral: Questionnaire

Studies Shown (1-50)

Next (51-100)

RSS Feed for studies found by your search that were received in the last 14 days

Download Options